Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food
Clinical trial NCT02852876 · COMPLETED
Trial details
- NCT number
- NCT02852876
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2005-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.